Valiant Laboratories IPO: Issue subscribed 25% so far on day 1; check GMP, other key details

livemint.com:

₹152 crore from the share sale. Valiant Laboratories specialises in manufacturing Paracetamol as an Active Pharmaceutical Ingredient (API) or Bulk Drug. A manufacturing facility owned by Valiant Laboratories is located in Palghar, Maharashtra, India.

Read here: Valiant Laboratories IPO opens: GMP, issue details, 10 key things to know Let us take a look at Valiant Laboratories IPO subscription status, GMP today and other key details: Valiant Laboratories IPO has been subscribed 25% so far on Wednesday, the first day of the bidding process. As per the data available on National Stock Exchange (NSE), the public issue received bids for 18.88 lakh equity shares as against 76.23 lakh shares on the offer, till 2:40 pm. The IPO has been booked 47% in the retail category and 5% in the Non-Institutional Investors’ category so far.

The Qualified Institutional Buyers (QIB) are yet to place their bids. Exciting news! Mint is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest financial insights! Click here! Valiant Laboratories IPO GMP today, or grey market premium today, is ₹0, as per market observers. This means Valiant Laboratories shares were trading at their issue price of ₹140 with no premium or discount in the grey market.

Also Read: JSW Infra IPO: Issue booked over 13 times on last day so far; check GMP, should you subscribe? Valiant IPO opened for subscription on Wednesday, September 27, and will close on Tuesday, October 3. Valiant Laboratories IPO's basis of allotment of shares is expected to be finalised on October 5 and the company will initiate refunds on October 6, while the shares will be credited to the demat account of allottees on the same day. Valiant Laboratories shares